⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Phenobarbital IV (neonatal seizures)
فنوباربیتال وریدی (نوزاد)
🧠 Nervous SystemBarbiturate anticonvulsant
🤰 Pregnancy:Dangerous / avoid👶 Children:Use with caution 🇮🇷 Registered in Iran⛔ 1 contraindications 🇺🇸 FDA approved (NDA) NDA215910ATC N03AA02
Market / country: 🇺🇸 USA
Sezaby (US)
🧮 Dose calculator
Neonatal seizures · Regimen source: FDA Sezaby · 2.1, Table 1
- • If seizures persist 15 min after the loading dose: a second dose (preterm 10 or 20 mg/kg; term 20 mg/kg). Total loading max 40 mg/kg. Into a large peripheral vein. FDA Sezaby · 2.1, Table 1
- • Iran also has 100 and 200 mg/mL ampoules (Darooyab); the volume shown is for the 10 mg/mL reconstituted powder — with an Iranian ampoule compute the volume from the mg dose and that ampoule’s strength. Darooyab · G-677/Phenobarbital
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Acute porphyria; hypersensitivity to phenobarbital or barbiturates. FDA Sezaby · 4
Formulations
- 100 mg vial (10 mg/mL after reconstitution with 10 mL) — powder for injection 🇺🇸 USA FDA Sezaby · 3FDA Sezaby · 2.2
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Darooyab: category D — evidence of fetal risk; only when essential. Darooyab · G-677/Phenobarbital — مصرف در بارداری
“مصرف در بارداری فنوباربیتال گروه D استفاده نشود:”
- 🤱 BreastfeedingNo data
The source for this drug has no section for this group.
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Sezaby · 8.4
“The safety and effectiveness of SEZABY have been established for the treatment of neonatal seizures in term and preterm infants, and the information on this use is discussed throughout the labeling.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA215910
- DailyMed (FDA label)FDA Sezaby
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDN03AA02
- Darooyab (Iran)Phenobarbital
🇮🇷 Registered in Iran Darooyab · G-677/Phenobarbital
Dosage forms with Iranian generic codes, per Darooyab.
- 00979 · PHENOBARBITAL 100MG TAB · قرص فنوباربیتال ۱۰۰ میلیگرم
- 00980 · PHENOBARBITAL 15MG TAB · قرص فنوباربیتال ۱۵ میلیگرم
- 11601 · PHENOBARBITAL 15MG/5ML SYRUP · شربت فنوباربیتال ۱۵ میلیگرم / ۵ میلیلیتر
- 00978 · PHENOBARBITAL 20MG/5ML ELIXIR 60ML · الگزیر فنوباربیتال ۲۰ میلیگرم / ۵ میلیلیتر ۶۰ میلیلیتر
- 00981 · PHENOBARBITAL 30MG TAB · قرص فنوباربیتال ۳۰ میلیگرم
- 00982 · PHENOBARBITAL 60MG TAB · قرص فنوباربیتال ۶۰ میلیگرم
- 01633 · PHENOBARBITAL SODIUM 100MG/1ML AMP · آمپول فنوباربیتال سدیم ۱۰۰ میلیگرم / ۱ میلیلیتر
- 00977 · PHENOBARBITAL SODIUM 200MG/1ML AMP · آمپول فنوباربیتال سدیم ۲۰۰ میلیگرم / ۱ میلیلیتر
- 07169 · PHENOBARBITAL SODIUM 200MG/2ML AMP · آمپول فنوباربیتال سدیم ۲۰۰ میلیگرم / ۲ میلیلیتر
- 53088 · PHENOBARBITAL ELIXIR ORAL 15 mg/5mL 60 mL · الگزیر فنوباربیتال ۱۵ میلیگرم / ۵ میلیلیتر ۶۰ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Sezaby · 3FDA Sezaby · 2.2FDA Sezaby · 2.1, Table 1FDA Sezaby · 4FDA Sezaby · 8.4FDA Sezaby · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-677/PhenobarbitalDarooyab · G-677/Phenobarbital — مصرف در بارداری
- Clinical review⚠ Unverified